QuidelOrtho EBITDA Margin 2010-2024 | QDEL
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for QuidelOrtho (QDEL) over the last 10 years. The current EBITDA margin for QuidelOrtho as of December 31, 2024 is .
| QuidelOrtho EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-12-31 | $2.78B | $0.32B | 11.35% |
| 2024-09-30 | $2.82B | $0.38B | 13.63% |
| 2024-06-30 | $2.84B | $0.40B | 13.93% |
| 2024-03-31 | $2.86B | $0.48B | 16.91% |
| 2023-12-31 | $3.00B | $0.60B | 19.91% |
| 2023-09-30 | $3.12B | $0.64B | 20.63% |
| 2023-06-30 | $3.16B | $0.67B | 21.07% |
| 2023-03-31 | $3.11B | $0.71B | 22.68% |
| 2022-12-31 | $3.27B | $1.13B | 34.52% |
| 2022-09-30 | $3.04B | $1.32B | 43.35% |
| 2022-06-30 | $2.76B | $1.45B | 52.50% |
| 2022-03-31 | $2.33B | $1.36B | 58.34% |
| 2021-12-31 | $1.70B | $0.96B | 56.44% |
| 2021-09-30 | $1.87B | $1.19B | 63.66% |
| 2021-06-30 | $1.84B | $1.22B | 66.30% |
| 2021-03-31 | $1.86B | $1.28B | 68.80% |
| 2020-12-31 | $1.66B | $1.11B | 66.73% |
| 2020-09-30 | $1.01B | $0.53B | 53.03% |
| 2020-06-30 | $0.66B | $0.25B | 37.56% |
| 2020-03-31 | $0.56B | $0.17B | 30.30% |
| 2019-12-31 | $0.53B | $0.15B | 28.09% |
| 2019-09-30 | $0.52B | $0.14B | 27.96% |
| 2019-06-30 | $0.51B | $0.16B | 32.21% |
| 2019-03-31 | $0.50B | $0.13B | 26.75% |
| 2018-12-31 | $0.52B | $0.16B | 29.89% |
| 2018-09-30 | $0.50B | $0.14B | 26.79% |
| 2018-06-30 | $0.44B | $0.09B | 19.63% |
| 2018-03-31 | $0.37B | $0.09B | 24.13% |
| 2017-12-31 | $0.28B | $0.05B | 17.27% |
| 2017-09-30 | $0.22B | $0.04B | 18.52% |
| 2017-06-30 | $0.21B | $0.04B | 20.56% |
| 2017-03-31 | $0.22B | $0.05B | 21.86% |
| 2016-12-31 | $0.19B | $0.03B | 13.09% |
| 2016-09-30 | $0.19B | $0.02B | 11.58% |
| 2016-06-30 | $0.19B | $0.02B | 11.17% |
| 2016-03-31 | $0.18B | $0.02B | 10.33% |
| 2015-12-31 | $0.20B | $0.03B | 15.82% |
| 2015-09-30 | $0.21B | $0.04B | 20.10% |
| 2015-06-30 | $0.20B | $0.03B | 15.27% |
| 2015-03-31 | $0.20B | $0.03B | 15.08% |
| 2014-12-31 | $0.18B | $0.02B | 10.33% |
| 2014-09-30 | $0.17B | $0.01B | 2.92% |
| 2014-06-30 | $0.16B | $0.01B | 5.49% |
| 2014-03-31 | $0.16B | $0.01B | 6.75% |
| 2013-12-31 | $0.18B | $0.03B | 16.85% |
| 2013-09-30 | $0.18B | $0.05B | 25.00% |
| 2013-06-30 | $0.18B | $0.05B | 26.82% |
| 2013-03-31 | $0.18B | $0.05B | 28.33% |
| 2012-12-31 | $0.16B | $0.03B | 21.15% |
| 2012-09-30 | $0.14B | $0.02B | 13.57% |
| 2012-06-30 | $0.14B | $0.02B | 13.57% |
| 2012-03-31 | $0.14B | $0.02B | 11.68% |
| 2011-12-31 | $0.16B | $0.03B | 19.50% |
| 2011-09-30 | $0.15B | $0.03B | 16.99% |
| 2011-06-30 | $0.15B | $0.02B | 14.86% |
| 2011-03-31 | $0.15B | $0.02B | 13.79% |
| 2010-12-31 | $0.11B | $0.00B | -2.65% |
| 2010-09-30 | $0.15B | $0.03B | 18.92% |
| 2010-06-30 | $0.18B | $0.05B | 30.68% |
| 2010-03-31 | $0.18B | $0.06B | 34.09% |
| 2009-12-31 | $0.17B | $0.06B | 35.76% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.868B | $2.783B |
| QuidelOrtho is a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems. The company's brand names include Sofia(R), Solana(R), Lyra(R), Triage(R) and QuickVue(R). Its comprehensive product portfolio includes tests for a range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. QuidelOrtho, formerly known as Quidel Corporation, is based in SAN DIEGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.702B | 27.74 |
| Boston Scientific (BSX) | United States | $154.217B | 38.61 |
| Stryker (SYK) | United States | $145.561B | 30.44 |
| EssilorLuxottica (ESLOY) | France | $133.244B | 0.00 |
| Medtronic (MDT) | Ireland | $107.028B | 15.63 |
| Lonza Group Ag (LZAGY) | Switzerland | $52.631B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.943B | 27.26 |
| ResMed (RMD) | United States | $35.287B | 26.50 |
| GE HealthCare Technologies (GEHC) | United States | $31.763B | 15.08 |
| Agilent Technologies (A) | United States | $30.897B | 20.41 |
| Terumo (TRUMY) | Japan | $29.152B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $24.100B | 17.21 |
| Insulet (PODD) | United States | $18.209B | 77.71 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.901B | 11.50 |
| Baxter (BAX) | United States | $15.608B | 11.66 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.425B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $7.970B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $7.395B | 18.18 |
| Bio-Rad Laboratories (BIO) | United States | $6.728B | 22.75 |
| Prestige Consumer Healthcare (PBH) | United States | $4.111B | 19.62 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.444B | 9.86 |
| ICU Medical (ICUI) | United States | $3.347B | 28.51 |
| Haemonetics (HAE) | United States | $3.139B | 14.77 |
| Envista Holdings (NVST) | United States | $2.876B | 23.90 |
| GN Store Nord (GNNDY) | Denmark | $2.071B | 17.15 |
| LeMaitre Vascular (LMAT) | United States | $1.817B | 40.63 |
| AtriCure (ATRC) | United States | $1.439B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.359B | 21.40 |
| Neogen (NEOG) | United States | $1.224B | 15.67 |
| AdaptHealth (AHCO) | United States | $1.173B | 11.30 |
| Kestra Medical Technologies (KMTS) | United States | $1.159B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.150B | 0.00 |
| InMode (INMD) | Israel | $0.991B | 9.08 |
| Phibro Animal Health (PAHC) | United States | $0.791B | 12.13 |
| Evolus (EOLS) | United States | $0.774B | 0.00 |
| Owens & Minor (OMI) | United States | $0.632B | 5.38 |
| Curaleaf Holdings (CURLF) | Canada | $0.618B | 0.00 |
| CeriBell (CBLL) | United States | $0.583B | 0.00 |
| Valneva SE (VALN) | France | $0.557B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.539B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.470B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.442B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.437B | 0.00 |
| Omeros (OMER) | United States | $0.397B | 0.00 |
| Surmodics (SRDX) | United States | $0.386B | 0.00 |
| SNDL (SNDL) | Canada | $0.355B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.348B | 15.09 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.312B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.290B | 26.18 |
| Sanara MedTech (SMTI) | United States | $0.288B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.265B | 47.20 |
| Sanuwave Health (SNWV) | United States | $0.265B | 0.00 |
| Cerus (CERS) | United States | $0.249B | 0.00 |
| ZimVie (ZIMV) | United States | $0.247B | 14.80 |
| Canopy Growth (CGC) | Canada | $0.234B | 0.00 |
| Quanterix (QTRX) | United States | $0.225B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.221B | 0.00 |
| High Tide (HITI) | Canada | $0.192B | 0.00 |
| Biote (BTMD) | United States | $0.178B | 4.06 |
| Utah Medical Products (UTMD) | United States | $0.172B | 13.83 |
| TriSalus Life Sciences (TLSI) | United States | $0.165B | 0.00 |
| Brainsway (BWAY) | Israel | $0.164B | 51.24 |
| Organigram Global (OGI) | Canada | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.145B | 17.91 |
| Jin Medical (ZJYL) | China | $0.125B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.118B | 0.00 |
| Exagen (XGN) | United States | $0.113B | 0.00 |
| Agape ATP (ATPC) | $0.105B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.103B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.093B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.081B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.61 |
| Veru (VERU) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| United Health Products (UEEC) | United States | $0.057B | 0.00 |
| ImmuCell (ICCC) | United States | $0.047B | 0.00 |
| Apyx Medical (APYX) | United States | $0.044B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.041B | 59.50 |
| Safety Shot (SHOT) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 11.31 |
| Nephros (NEPH) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |